Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Phase II clinical trial of sorafenib in metastatic medullary thyroid cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase II clinical trial of sorafenib in metastatic medullary thyroid cancer.
Phase II clinical trial of sorafenib in metastatic medullary thyroid cancer. J Clin Oncol. 2010 May 10; 28(14):2323-30.
View in:
PubMed
subject areas
Administration, Oral
Adult
Aged
Benzenesulfonates
Biomarkers, Tumor
Carcinoma, Medullary
Disease-Free Survival
Female
Humans
Kaplan-Meier Estimate
Magnetic Resonance Imaging
Male
Middle Aged
Mutation
Niacinamide
Phenylurea Compounds
Positron-Emission Tomography
Protein Kinase Inhibitors
Proto-Oncogene Proteins c-ret
Pyridines
Receptors, Vascular Endothelial Growth Factor
Thyroid Neoplasms
Time Factors
Tomography, X-Ray Computed
Treatment Outcome
United States
Young Adult
authors with profiles
Steffen Sammet